Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Add-on in Opioid and Multiple Substance Dependence
NCT01189214Phase 3Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Mar 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in opioid use disorder (OUD), substance use disorder (SUD), sponsored by National Cheng Kung University Hospital. Started Mar 2009; status: completed.
02
Drugs
memantine
03
Conditions
opioid use disorder (OUD)substance use disorder (SUD)
Beyond the preview
Go deeper on NCT01189214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189214.